The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension

NCT07013149 · clinicaltrials.gov ↗

RECRUITING

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Interventions

OTHER: Switch from Ambrisentan to Bosentan

Sponsor

University of Sao Paulo General Hospital